Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 1052 | 1116 | 1001 | 1232 | 1471 |
Fund Return | 5.15% | 5.15% | 11.58% | 0.03% | 4.26% | 3.93% |
Place in category | 705 | 705 | 861 | 1906 | 515 | 329 |
% in Category | 24 | 24 | 30 | 79 | 27 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DWS Akkumula LD | 9.12B | 9.75 | 10.02 | 11.47 | ||
DWS Akkumula ID | 9.12B | 9.98 | 10.96 | 12.25 | ||
DWS Dynamic Opportunities LC | 3.53B | 5.63 | 4.26 | 7.09 | ||
DWS Aktien Strategie Deutschland FC | 2.25B | 6.25 | 2.17 | 7.70 | ||
DWS Aktien Strategie Deutschland ID | 2.25B | 6.33 | 2.48 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PrivatFonds: Kontrolliert pro | 2.4B | 7.85 | 4.33 | 4.03 | ||
BBBank Kontinuitat Union | 1.31B | 5.94 | 2.44 | 3.52 | ||
Substanz Fonds | 1.2B | 4.58 | 1.38 | 5.03 | ||
UniStrategie:Ausgewogen | 1.07B | 2.93 | 1.68 | 3.89 | ||
Allianz Strategiefonds Balance PT2 | 909.52M | 4.29 | 6.34 | 6.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
db x-trackers MSCI EM Asia UCITS 1C | LU0292107991 | 6.23 | 50.50 | +0.60% | |
Xtrackers IE Physical Gold EUR Hedged ETC Securiti | DE000A2T5DZ1 | 4.51 | 30.74 | -0.09% | |
Lyxor Core MSCI Japan (DR) | LU1781541252 | 4.44 | 17.23 | +0.29% | |
Novo Nordisk A/S Class B | DK0060534915 | 2.46 | - | - | |
Tui | DE000TUAG505 | 1.89 | 6.722 | +2.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review